The amyloidosis fellowship will be led by Sabahat Bokhari, MD, director of the Cardiac Amyloidosis and Cardiomyopathy Center at RWJUH and RWJMS, according to a Dec. 17 news release from Rutgers University.
Amyloidosis is “significantly underdiagnosed,” and without proper care patients may have six months to less than five years to live. The Amyloidosis and Cardiomyopathy Center has treated more than 600 patients with the condition since 2022, the release said.
Dr. Bokhari is credited with pioneering a widely used, noninvasive imaging method for the evaluation of cardiac transthyretin amyloidosis.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
